April 2020: an ambulance picks up a possible covid patient near Liège. Whether the pill really makes a difference – and thus reduces the risk of hospitalization – will be known in September or October. — © afp
The drug company Merck is investigating whether molnupiravir can prevent the first symptoms from derailing into severe covid-19. It is one of the few drugs in the pipeline to avoid hospital admissions.
Read Also
- Prevent Premature Aging, Doctors Suggest Routinely Use Sunscreen! Apr 16, 2021
- Covid Italia, Ricciardi: “Vaccine for many or pandemic until 2024” Aug 26, 2021
- They find a colonial cemetery with 42 burials in an old hospital in Peru May 29, 2022
- In Ukraine officially kicked off IFA-antibody testing COVID-19 May 21, 2020
- Cancer, new discovery: here’s how to make chemotherapy more effective Aug 25, 2021
- Jurassic Park: The Doctor Collector welcome box is soon out of stock May 21, 2022
- Franco Escamilla’s wife is hospitalized: “I ask you to pray” May 18, 2022
Maxie Eckert
Today at 11:34 AM
.
